NEW DELHI: In a move that will shape India’s future strategy of Covid vaccination and management, the government’s top scientific advisory group on immunisation, the National Technical Advisory Group on Immunisation (NTAGI) for Covid-19, is evaluating data about the “value of all vaccines” and their “relative importance” in a situation where over 97% of cases are infected with the Omicron variant, sources said.
“NTAGI is likely to make recommendations in around two weeks, based on which the government will take a call to modify the Covid vaccination policy. A final decision is likely to be taken in early March,” a senior official told TOI.
